Fundraising Fox

Convergent Therapeutics

Cambridge, US · Founded 2020 · Delaware corporation · 1 known investors

Biotech

Founders & leadership

PK
Philip KantoffExecutive Officer, Director
NB
Neil BanderExecutive Officer, Director
ES
Eric SullivanExecutive Officer
AB
Alexander BrownExecutive Officer
JS
Jake SimsonDirector
TZ
Tal ZaksDirector
JT
Jim TrenkleDirector

Investors · 1

RA CapitalreportedBostonvia Jake Simson · board

Reported raises · per SEC filings

Form D private placements
▶$22.2MraisedAug 2024 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Eric SullivanExecutive Officer
  • Jake SimsonDirector
  • Tal ZaksDirector
  • Jim TrenkleDirector
  • Philip KantoffExecutive Officer, Director
  • Alexander BrownExecutive Officer
  • Neil BanderExecutive Officer, Director
Offering amount
$40M
Amount sold
$22.2M
First sale
Jul 2024
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$29.2MraisedMay 2023 · 15 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Neil BanderDirector
  • Jake SimsonDirector
  • Philip KantoffExecutive Officer, Director
  • Alexander BrownExecutive Officer
  • Tal ZaksDirector
Offering amount
$99.2M
Amount sold
$29.2M
First sale
Apr 2023
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.